Business Wire

SOLASIA-PHARMA

Share
Solasia Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan

Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) today announced submission of a New Drug Application (NDA) for its new anti-cancer drug darinaparsin (generic name, development code: SP-02) as a treatment for relapsed or refractory peripheral T-cell lymphoma to the Ministry of Health, Labour and Welfare (MHLW). Based on positive results of R&D on darinaparsin, centered primarily on the results of the Asian Multinational Phase 2 Study (study results released in June 2020), Solasia filed an NDA for the drug with the regulatory authority in Japan ahead of anywhere else in the world.

Solasia expects to obtain regulatory approval in 2022 and to also launch in the same year. If approved and launched, darinaparsin would be the third drug Solasia successfully developed and brought to market since its founding and is expected to contribute to the treatment of PTCL.

Mr. Yoshihiro Arai, President and CEO of Solasia, commented as follows:
“No standard treatment has been established for relapsed or refractory PTCL as of yet. I firmly believe that darinaparsin, with its novel mechanism of action that differs from those of already approved drugs, will contribute to patients and healthcare providers at clinical sites as a new treatment option for relapsed or refractory PTCL. Since founding, Solasia has conducted R&D on five pipeline drugs. Of the five, we have successfully developed and brought to market two drugs, i.e., began providing them to patients, and today, we submitted an NDA for our first anti-cancer drug. Under our mission to provide patients with ‘Better Medicine for a Brighter Tomorrow’, we will continue aiming to contribute to patients’ treatment and enhanced quality of life. ”

About darinaparsin (SP-02)
Darinaparsin, an organoarsenic compound with anticancer activity, is a novel mitochondrial-targeted agent being developed for the treatment of various hematologic and solid tumors. The proposed mechanism of action of the drug involves the disruption of mitochondrial function, increased production of reactive oxygen species, and modulation of intracellular signal transduction pathways. Darinaparsin is believed to exert anticancer effect by inducing cell cycle arrest and apoptosis. Darinaparsin has been granted orphan drug designation in the US and EU.
For more information, please visit at https://solasia.co.jp/en/pipeline/sp-02.html

About Asian Multinational Phase 2 Study
The Asian Multinational Phase 2 Study was a multinational, multicenter, single-arm, open-label, non-randomized study to evaluate the efficacy and safety of darinaparsin monotherapy in patients with relapsed or refractory PTCL conducted in Japan, Korea, Taiwan, and Hong Kong. (CT.gov Identifier: NCT02653976).
Solasia plans to present the results of the study at an international academic conference to be held in the near future.

About peripheral T-cell lymphoma (PTCL)
Please visit at https://solasia.co.jp/en/pipeline/sp-02.html

About Solasia
Please visit at https://solasia.co.jp/en/

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fanatics Collectibles and Kayou Join Forces to Bring NBA Trading Cards to China3.10.2025 04:00:00 CEST | Press release

NBA Match Attax 2025 to launch on Oct. 3 at retail locations across ChinaFanatics Collectibles kicks off licensed basketball with presence at NBA China Games Fanatics Collectibles, via Topps, and Kayou have announced today a partnership to provide NBA trading cards to China through NBA Match Attax 2025. The deal represents a landmark product offering accessible NBA trading cards for basketball fans in China and further growing the country’s passion for the sport. As part of the deal, Kayou, a leading trading card manufacturer in China, will handle the manufacturing and distribution of the product, leveraging its expansive existing distribution network, while Topps will utilize its world class design to delight Chinese fans and collectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002665209/en/ The deal underscores Fanatics Collectibles’ commitment to growing the Chinese market, as well as its international growth str

With the Redevelopment Works Underway, UCC Holding on behalf of the JV Partners Signs Five Design and Consultancy Agreements with Global Firms for the Development of Damascus International Airport2.10.2025 20:37:00 CEST | Press release

UCC Holding, on behalf of the JV partners and through its subsidiary Urbacon Airports, has signed five consultancy and design agreements as part of the Damascus International Airport comprehensive redevelopment project. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002746016/en/ UCC Holding on behalf of the JV Partners Signs Five Design and Consultancy Agreements with Global Firms for the Development of Damascus International Airport (Photo: AETOSWire) Scopes include the redevelopment of the airport and all associated facilities — a phased redevelopment designed to reach 31 million passengers annually. This includes the refurbishment of existing terminals and buildings, as well as the design and development of a new five-star hotel adjacent to the airport, featuring 200 premium rooms, multiple dining and leisure facilities, and direct terminal access. The hotel will be managed and operated by an internationally recognize

Stefanini Group Ranked Exceptional Performer for Customer Satisfaction by Whitelane 2025 Swiss IT Sourcing Study2.10.2025 19:52:00 CEST | Press release

The tech company achieved the highest general satisfaction ranking with scores of 85% in the Whitelane Research study. Stefanini Group, a global technology company specializing in digital transformation and AI solutions, announced today that it was awarded the title “Exceptional Performer” for General Customer Satisfaction and Workplace Services in the Whitelane 2025 Swiss IT Sourcing Study. Debuting in the research this year, Stefanini achieved the highest general satisfaction ranking with scores of 85%, compared to the industry average of 78 percent. The company was also ranked number one for Workplace Services (83% vs. 79% industry average), considering several key performance indicators (KPIs). “All Stefanini KPI scores are great, but Account Management is truly outstanding (94% compared with 79% industry average). This KPI evaluates how Stefanini manages their relationship with clients, from a strategic and commercial perspective, and identifies new areas for cooperation and impro

Andersen Consulting udvider sine kapaciteter i Mauritius og Seychellerne2.10.2025 19:12:00 CEST | Pressemeddelelse

Andersen Consulting styrker sine kapaciteter med tilføjelsen af samarbejdspartneren Perigeum Capital Ltd, der er en førende rådgivningsvirksomhed inden for virksomhedsfinansiering med hovedkontor i Mauritius og kontor i Seychellerne. Perigeum Capital tilbyder en omfattende portefølje af professionelle tjenester, herunder rådgivning inden for virksomhedsfinansiering, kapitalmarkedsløsninger, fusion og opløb, værdiansættelse, it-konsulentydelser, compliance, ledelse og ESG-rådgivning. Med ekspertise inden for både lokale, regionale og internationale regulatoriske rammer samarbejder virksomheden med organisationer gennem hele deres vækst- og transformationsrejser. Virksomhedens kapaciteter suppleres af specialiseret viden inden for teknologi – herunder kunstig intelligens, cybersikkerhed samt data og analyse – hvilket øger dybden og resiliensen af deres rådgivning. Denne integrerede tilgang gør Perigeum Capital til en komplet og pålidelig ressource til helhedsorienterede rådgivnings- og t

Zayed Sustainability Prize Announces 2026 Finalists Driving Global Impact2.10.2025 17:51:00 CEST | Press release

33 finalists selected from 7,761 submissions across 173 countriesThis year’s finalists are pioneering inclusive, tech-enabled, and locally adapted solutions that tackle urgent global challenges—delivering clean energy, safe water, nutritious food, quality healthcare, and climate resilience to millions worldwideThe Prize’s global impact has reached over 400 million lives, demonstrating the power of innovation to transform communities and shape a sustainable future The Zayed Sustainability Prize, the UAE’s pioneering award for innovative solutions to global challenges, has announced this year’s finalists following a rigorous evaluation by its esteemed Jury. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002639589/en/ The Zayed Sustainability Prize convened in Abu Dhabi to select the 33 finalists of the 2026 edition (Photo: AETOSWire) The winners will be revealed at the Zayed Sustainability Prize Awards Ceremony on 13 Januar

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye